More Company News

Scancell

H1 2019 business update
01 Jul 2019Read More

Scancell

Board appointment
18 Jun 2019Read More

Scancell

Share subscription and issue of equity to Vulpes Life Sciences Fund
13 Jun 2019Read More

Scancell

Update on SC1B2 development
20 May 2019Read More

Scancell

Establishment of Clinical Advisory Board and update on Modi1 progress
10 May 2019Read More

Scancell

UK regulatory approval to start SCIB1 Phase II advanced melanoma trial
25 Apr 2019Read More

Scancell

Grant of Japanese patent that protects Moditope immunotherapy platform
08 Apr 2019Read More

Scancell

CSO receives Waldenstrom award from Swedish Society of Oncology
21 Mar 2019Read More

Scancell

IP portfolio strengthened
20 Mar 2019Read More

Scancell

Interim H119 results
31 Jan 2019Read More

1 2
Return to Scancell
© 2019 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).